PTCH1 and chronic myelogenous leukemia, BCR-ABL1 positive: Initial studies revealed that the expression of GLI1 and PTCH1 progressively increased in CML patient cells from the chronic phase (CP) through the accelerated phase (AP) and blast crisis phase (BC) of the disease [38,58,59].